Table 1 Patients’ characteristics, according to their survival status or nursing home admission over follow-up

Age (years)

79.4 (5.3)

78.9 (5.2)

81.6 (5.4)

.07

79.4 (5.4)

79.6 (5.2)

.84

Male gender % (N)

57.1 (56)

52.5 (42)

77.8 (14)

.07

57.0 (45)

57.9 (11)

1.00

PD duration (Y)

3.8 (3.6)

3.8 (3.7)

3.7 (3.1)

.85

3.7 (3.7)

4.2 (3.1)

.59

UPDRS part III score [0–108]

14.6 (5.1)

14.5 (4.8)

15.2 (6.4)

.68

14.8 (5.1)

14.1 (5.1)

.62

UPDRS axial score [0–24]

7.9 (3.3)

7.8 (3.1)

8.3 (4.0)

.54

7.9 (3.3)

7.6 (3.4)

.68

Levodopa equivalent dose (mg)

368.5 (212.0)

368.5 (224.3)

368.8 (143.6)

1.00

364.9 (210.1)

385.9 (226.9)

.72

Weight (kg)

65.1 (11.7)

64.8 (11.8)

66.4 (11.5)

.66

65.4 (12.1)

63.9 (10.5)

.62

MMSE [0–30]

25.6 (3.8)

25.8 (3.5)

24.8 (5.4)

.53

25.7 (3.8)

25.1 (4.1)

.65

Grip strength (kg)

22.7 (8.0)

23.1 (8.2)

20.6 (6.5)

.25

22.9 (8.4)

21.8 (5.6)

.59

ADL score [0–6]

5.5 (0.8)

5.5 (0.9)

5.6 (0.7)

.80

5.5 (0.8)

5.6 (0.8)

.70

IADL score [0–4]

3.3 (1.1)

3.3 (1.0)

3.1 (1.2)

.38

3.2 (1.1)

3.2 (1.0)

.75

Gait speed (m/s)

0.8 (0.3)

0.8 (0.3)

0.7 (0.3)

.038

0.8 (0.2)

0.8 (0.4)

.81

TUG (s)

18.1 (9.2)

17.5 (9.0)

20.6 (9.8)

.24

18.1 (9.5)

18.0 (8.2)

.94

TUGc (s)

24.9 (15.7)

24.4 (15.2)

27.0 (18.2)

.57

24.5 (15.7)

26.1 (16.0)

.51

Tinetti balance score [0–16]

13.3 (2.7)

13.7 (2.1)

11.6 (4.0)

.002

13.4 (2.6)

13.2 (2.5)

.70

Tinetti gait score [0–12]

9.1 (2.7)

9.2 (2.7)

8.6 (2.6)

.42

9.1 (2.8)

9.2 (2.1)

.90

Number of drugs

5.1 (2.7)

5.1 (2.7)

5.3 (2.7)

.72

5.1 (2.8)

5.4 (2.3)

.55

CIRS-G score [0–56]

6.4 (2.1)

6.2 (2.0)

7.2 (2.5)

.13

6.4 (2.2)

6.4 (1.8)

1.00